266:
33:
285:. At the same time, it established the federal Patented Medicine Prices Review Board. The board determines a maximum price for individual drugs through a review process, and negotiates "voluntary compliance agreements" with drug companies to ensure that "manufacturer prices are within justification, and not excessive".
302:
According to their annual report for the fiscal year 2017, there were 1,391 patented medicines for human use that were reported, which included 80 new medicines. By
December 31, 2017, there were 14 voluntary compliance undertakings accepted. Patented medicines represented 61.5% of the total medicine
343:
Liberal government has proceeded with subsequent regulatory changes designed to reduce the prices
Canadian drug insurers pay for patented medicines. The government has been criticized for their use of the Patent Act and the Patented Medicine Prices Review Board to drive cost savings for drug
294:. Sections 79 through to 103 of the Act set out the mandate, structure, appointment process, and jurisdiction of the Board. The objective of the board is to preventing manufacturers of patented medicines from charging excessive prices.
311:
Since 2017, the federal government has been working on passing regulatory changes to how the
Patented Medicine Prices Review Board (PMPRB) regulates the excessive pricing of patented medicines in Canada. The
277:
system under which drug patent holders were required to allow competing drug manufacturers to import their patented drug in exchange for a very modest 4% royalty, which resulted in an increase in the
624:"Canada Gazette, Part 2, Volume 156, Number 14: Regulations Amending the Regulations Amending the Patented Medicines Regulations (Additional Factors and Information Reporting Requirements), No. 5"
681:
709:
462:
425:
438:"Facing crackdown in Canada, drugmakers offered billions in price cuts: Delayed rules would change countries Canada compares its prices to, dropping U.S."
714:
212:
are not excessive. The board does this through its role as a regulator, and through its reporting on trends, research and development in the
563:
213:
660:
368:
392:
349:
240:
115:
254:
623:
205:
204:
regulatory and reporting agency in Canada with a mandate to protect consumers by ensuring that the prices of
416:
313:
209:
317:
609:
531:
274:
236:
333:
249:
201:
219:
The board investigates, reviews and negotiates the price of individual drugs that are still under
165:
505:
288:
The PMPRB is an independent federal quasi-judicial body established through
Section 91 of the
672:
497:
265:
193:
437:
340:
253:, the board produces an annual report submitted to the minister, who tables it in the
227:. It establishes the maximum prices that can be charged in Canada for patented drugs.
703:
282:
485:
328:(2022) rebuked the federal government's initially-proposed changes to the PMPRB as
278:
224:
111:
622:
Government of Canada, Public Works and
Government Services Canada (2022-07-06).
329:
244:
290:
501:
509:
345:
417:"Prescription Drug Prices in Canada: What Are the Lessons for the U.S.?"
685:
247:
responsible for the health portfolio. Under sections 89 and 100 of the
32:
651:
220:
76:
66:
564:"The New Role of the Patented Medicine Prices Review Board (PMPRB)"
264:
108:
348:
and for the potential cooling effect this may have in bringing
94:
608:
1998. Report of the
Patented Medicine Prices Review Board.
584:
682:"In Canada, a little-known drug regulator shows its teeth"
661:"How Does Canada Keep a Lid On Prescription Drug Costs?"
486:"Pharmaceutical Cost Control in Canada: Does It Work?"
479:
477:
475:
269:
Patented
Medicine Prices Review Board office in Ottawa
680:
Martell, Allison; Paperny, Anna Mehler (8 May 2019).
273:Bill C-22, which was passed in 1987, established a
160:
144:
124:
101:
90:
82:
72:
62:
44:
39:
532:"Consolidated federal laws of Canada, Patent Act"
198:Conseil d'examen du prix des médicaments brevetés
24:Conseil d'examen du prix des médicaments brevetés
579:
577:
326:Merck Canada inc. v Procureur général du Canada
303:sales in Canada in 2017 up from 60.8% in 2016.
426:Prescription drug prices in the United States
8:
22:
16:
530:Branch, Legislative Services (2021-06-30).
134:MĂ©lanie Bourassa Forcier, Vice-chairperson
31:
710:Independent government agencies of Canada
360:
15:
322:Innovative Medicines Canada v. Canada
186:Patented Medicine Prices Review Board
17:Patented Medicine Prices Review Board
7:
557:
555:
553:
551:
14:
659:Mulligan, Kate (15 August 2003).
562:Moloney, Kieran (February 2022).
137:Douglas Clark, Executive Director
715:Pharmacy organizations in Canada
568:McGill Journal of Law and Health
214:Canadian pharmaceutical industry
174:/patented-medicine-prices-review
210:manufacturers of patented drugs
1:
610:Road Map for the Next Decade
484:Menon, Devidas (June 2001).
235:The board is accountable to
131:Mitchell Levine, Chairperson
50:; 37 years ago
731:
30:
21:
536:laws-lois.justice.gc.ca
502:10.1377/hlthaff.20.3.92
441:Thomson Reuters via CBC
612:Ottawa, Ontario. 36pp.
318:Quebec Court of Appeal
270:
197:
23:
268:
671:(16). Archived from
585:"Annual Report 2017"
463:"ANNUAL REPORT 2018"
350:innovative medicines
307:Recent PMPRB reforms
275:compulsory licensing
102:Minister responsible
628:canadagazette.gc.ca
225:generic substitutes
206:patented medication
18:
443:. February 6, 2019
421:AARP International
271:
241:Minister of Health
223:and which have no
116:Minister of Health
423:. Washington, DC.
397:www.tbs-sct.gc.ca
373:www.tbs-sct.gc.ca
182:
181:
125:Agency executives
722:
696:
694:
692:
676:
665:Psychiatric News
655:
654:
652:Official website
638:
637:
635:
634:
619:
613:
606:
600:
599:
597:
596:
581:
572:
571:
559:
546:
545:
543:
542:
527:
521:
520:
518:
516:
481:
470:
469:
467:
459:
453:
452:
450:
448:
434:
428:
424:
413:
407:
406:
404:
403:
389:
383:
382:
380:
379:
365:
255:House of Commons
245:elected official
178:
175:
173:
171:
169:
167:
58:
56:
51:
35:
26:
19:
730:
729:
725:
724:
723:
721:
720:
719:
700:
699:
690:
688:
679:
675:on 4 June 2004.
658:
650:
649:
646:
641:
632:
630:
621:
620:
616:
607:
603:
594:
592:
583:
582:
575:
561:
560:
549:
540:
538:
529:
528:
524:
514:
512:
483:
482:
473:
465:
461:
460:
456:
446:
444:
436:
435:
431:
415:
414:
410:
401:
399:
391:
390:
386:
377:
375:
367:
366:
362:
358:
309:
300:
263:
233:
200:) is a federal
164:
156:
140:
120:
54:
52:
49:
40:Agency overview
12:
11:
5:
728:
726:
718:
717:
712:
702:
701:
698:
697:
677:
656:
645:
644:External links
642:
640:
639:
614:
601:
573:
547:
522:
490:Health Affairs
471:
454:
429:
408:
384:
359:
357:
354:
308:
305:
299:
298:Annual reports
296:
262:
259:
232:
231:Accountability
229:
202:quasi-judicial
180:
179:
162:
158:
157:
155:
154:
148:
146:
142:
141:
139:
138:
135:
132:
128:
126:
122:
121:
119:
118:
105:
103:
99:
98:
92:
88:
87:
84:
80:
79:
74:
70:
69:
64:
60:
59:
46:
42:
41:
37:
36:
28:
27:
13:
10:
9:
6:
4:
3:
2:
727:
716:
713:
711:
708:
707:
705:
687:
683:
678:
674:
670:
666:
662:
657:
653:
648:
647:
643:
629:
625:
618:
615:
611:
605:
602:
590:
586:
580:
578:
574:
569:
565:
558:
556:
554:
552:
548:
537:
533:
526:
523:
511:
507:
503:
499:
495:
491:
487:
480:
478:
476:
472:
464:
458:
455:
442:
439:
433:
430:
427:
422:
418:
412:
409:
398:
394:
393:"GC InfoBase"
388:
385:
374:
370:
369:"GC InfoBase"
364:
361:
355:
353:
351:
347:
342:
338:
336:
331:
327:
323:
320:decisions in
319:
315:
314:Federal Court
306:
304:
297:
295:
293:
292:
286:
284:
283:generic drugs
280:
276:
267:
260:
258:
256:
252:
251:
246:
242:
238:
230:
228:
226:
222:
217:
215:
211:
207:
203:
199:
195:
191:
187:
177:
163:
159:
153:
150:
149:
147:
143:
136:
133:
130:
129:
127:
123:
117:
113:
110:
107:
106:
104:
100:
96:
93:
91:Annual budget
89:
85:
81:
78:
75:
71:
68:
65:
61:
47:
43:
38:
34:
29:
25:
20:
689:. Retrieved
673:the original
668:
664:
631:. Retrieved
627:
617:
604:
593:. Retrieved
591:. 2018-07-12
588:
567:
539:. Retrieved
535:
525:
513:. Retrieved
493:
489:
457:
445:. Retrieved
440:
432:
420:
411:
400:. Retrieved
396:
387:
376:. Retrieved
372:
363:
334:
325:
321:
310:
301:
289:
287:
279:market share
272:
248:
239:through the
234:
218:
189:
185:
183:
151:
145:Key document
112:Mark Holland
97:10.3 million
73:Headquarters
63:Jurisdiction
515:February 6,
447:February 6,
352:to Canada.
330:ultra vires
324:(2022) and
208:charged by
704:Categories
633:2023-03-08
595:2019-02-07
541:2023-03-08
402:2020-10-16
378:2020-10-16
356:References
335:Patent Act
291:Patent Act
261:Background
250:Patent Act
237:Parliament
152:Patent Act
83:Employees
510:11585186
496:: 1–12.
346:insurers
686:Reuters
341:Trudeau
168:.canada
161:Website
53: (
508:
243:, the
221:patent
194:French
77:Ottawa
67:Canada
45:Formed
691:8 May
589:PMPRB
466:(PDF)
190:PMPRB
176:.html
693:2019
517:2019
506:PMID
449:2019
339:The
332:the
316:and
184:The
109:Hon.
95:CA$
55:1987
48:1987
498:doi
281:of
172:/en
170:.ca
166:www
706::
684:.
669:38
667:.
663:.
626:.
587:.
576:^
566:.
550:^
534:.
504:.
494:20
492:.
488:.
474:^
419:.
395:.
371:.
257:.
216:.
196::
192:;
114:,
86:74
695:.
636:.
598:.
570:.
544:.
519:.
500::
468:.
451:.
405:.
381:.
337:.
188:(
57:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
